03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Marovarex 240mg : | |
Type | Medicine Authorised |
Originator | Tecfidera 240mg |
Agent | Droguerie Mercury |
Distributor | Droguerie Mercury |
Laboratory | Hikma Pharmaceuticals |
Responsible Party | Hikma Pharmaceuticals |
Origin | Jordan |
Manufacturer | Hikma Pharmaceuticals PLC |
Manufacturing Type | G |
Origin | Jordan |
ATC | L04AX07 |
Marovarex 240mg :
Marovarex 240mg :
Marovarex 240mg :
Marovarex 240mg :
Marovarex 240mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Abdominal pain upper | Very Common |
Albumin urine present | Common |
ALT increased | Common |
AST increased | Common |
Blood parathyroid hormone increased | Not known |
Burning sensation | Common |
Diarrhoea (Diarrhea) | Very Common |
Dyspepsia | Common |
Eosinophil count increased | Not known |
Erythema | Common |
Flushing | Very Common |
Gastritis | Common |
Gastroenteritis | Common |
Gastrointestinal disorders | Common |
Glomerular filtration rate increased | Not known |
Hot flush | Common |
Hypersensitivity | Uncommon |
Ketonuria | Very Common |
Leucopenia (Leukopenia) | Common |
Leukocyte count decreased (White blood cell count decreased) | Common |
Lymphocyte count decreased | Not known |
Lymphopenia | Common |
Nausea | Very Common |
Proteinuria | Common |
Pruritus | Common |
Sensation of heat (Feeling of warmth) (Sensation of warmth) | Common |
Skin rash | Common |
Transaminases increased | Not known |
Vomiting | Common |
Marovarex 240mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Marovarex 240mg MoH 11375 :
Form | Gastro-resistant capsule, hard |
Packaging | Blisters |
Package Size | Box of 56 |
Strength | 240mg |
Storage Condition | <30°C protect from light |
Public Price | 60848733.56 L.L. |
Stratum | E1 |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 79119/1 |
Submission date | 08/05/2019 |
Registration Year | 15/09/2022 |
Pending Year | 02/12/2020 |
Pending Reason | Incomplete file |
Price Comparison
● Country: | Jordan | |
● Package Size: | 56 | |
● Public Price: | 714.34 JOD | ( 89,450,369.14 LBP ) |
● Pack size unit used: | 56 | |
● Cost/Unit: | 12,7561 JOD | ( 1,502,652.00 LBP ) |
● Pharmacy Price: | 686.87 JOD | ( 86010548.27 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Gastro-resistant capsule, hard | |
● Package Size: | Box of 56 | |
● Public Price: | 60848733.56 LBP | ( 60,848,733.56 LBP ) |
● Pack size unit used: | 56 | |
● Cost/Unit: | 1086584,53 LBP | ( 1,086,584.00 LBP ) |
● Pricing Date: | 13/06/2024 |
You have to register to view this info
Drop File